Isolation of cancer stem cells from three human glioblastoma cell lines: Characterization of two selected clones

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Iacopino, Fortunata ^a   Angelucci, Cristiana ^a   Piacentini, Roberto ^a   Biamonte, Filippo ^a   Mangiola, Annunziato ^a   Maira, Giulio ^a   Grassi, Claudio ^a   Sica, Gigliola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE MEDIUM; TUMOR MARKER;

ANIMAL; BRAIN TUMOR; CANCER STEM CELL; CELL CLONE; CELL DIFFERENTIATION; CULTURE MEDIUM; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CLONE CELLS; CULTURE MEDIA; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS;

EID: 84905979145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105166     Document Type: Article

References (62)

1. Shibata M, Shen MM (2013) The roots of cancer: Stem cells and the basis for tumor heterogeneity. Bioessays 35(3): 253-260.
2. Cruz MH, Sidén A, Calaf GM, Delwar ZM, Yakisich JS (2012) The stemness phenotype model. ISRN Oncol 2012: 392647. doi:10.5402/2012/392647.
3. Chow EK (2013) Implication of Cancer Stem Cells in Cancer Drug Development and Drug Delivery. J Lab Autom 18(1): 6-11.
4. Pointer KB, Clark PA, Zorniak M, Alrfaei BM, Kuo JS (2014) Glioblastoma cancer stem cells: Biomarker and therapeutic advances. Neurochem Int 71C: 1-7.
5. Romaguera-Ros M, Peris-Celda M, Oliver-De La Cruz J, Carrión- Navarro J, Pérez-García A, et al. (2012) Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays. Stem Cell Rev 8(1): 288-298.
6. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, et al. (2013) Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J 27(1): 13-24.
7. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, et al. (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4(6): 568-580.
8. Gedye C, Ailles L (2013) Isolation and characterization of cancer stem cells in vitro. Methods Mol Biol 946: 181-204.
9. Hong X, Chedid K, Kalkanis SN (2012) Glioblastoma cell line-derived spheres in serum-containing medium versus serum-free medium: A comparison of cancer stem cell properties. Int J Oncol 41(5): 1693-1700.
10. Sampetrean O, Saya H (2013) Characteristics of glioma stem cells. Brain Tumor Pathol. 30(4): 209-214.
11. Jin X, Jin X, Jung JE, Beck S, Kim H (2013) Cell surface Nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun. 433(4): 496-501.
12. Kong BH, Park NR, Shim JK, Kim BK, Shin HJ, et al. (2013) Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens. Childs Nerv Syst. 29(2): 217-229.
13. Pavon LF, Marti LC, Sibov TT, Miyaki LA, Malheiros SM, et al. (2012) Isolation, cultivation and characterization of CD133+ stem cells from human glioblastoma. Einstein (Sao Paulo). 10(2): 197-202.
14. Binda E, Visioli A, Reynolds B, Vescovi AL (2012) Heterogeneity of cancer-initiating cells within glioblastoma. Front Biosci 4: 1235-1248.
15. Denysenko T, Gennero L, Roos MA, Melcarne A, Juenemann C, et al. (2010) Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies. Cell Biochem Funct 28(5): 343-351. Review.
16. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5818.
17. Wolańczyk M, Hułas-Bigoszewska K, Witusik-Perkowska M, Papierz W, Jaskólski D, et al. (2010) Imperfect oligodendrocytic and neuronal differentiation of glioblastoma cells. Folia Neuropathol 48(1): 27-34.
18. Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, et al. (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27(20): 2897-2909. (Pubitemid 351620450)
19. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, et al. (2009) Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 279(1): 13-21.
20. Jin F, Zhao L, Zhao HY, Guo SG, Feng J, et al. (2008) Paradoxical expression of anti-apoptotic and MRP genes on cancer stem-like cell isolated from TJ905 glioblastoma multiforme cell line. Cancer Invest 26(4): 338-343. (Pubitemid 351601388)
21. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Pro. Natl Acad Sci USA 101: 781-786. (Pubitemid 38121035)
22. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, et al. (2008) Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265(1): 124-134.
23. Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, et al. (2010) Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett 291(2): 150-157.
24. Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, et al. (2012) Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer 31(4): 207-14.
25. Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, et al. (2012) Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol 14(2): 132-144.
26. van Staveren WC, Solís DY, Hébrant A, Detours V, Dumont JE, et al. (2009) Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta 1795(2): 92-103.
27. Keysar SB, Jimeno A (2010) More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther 9(9): 2450-2457.
28. Calloni R, Cordero EA, Henriques JA, Bonatto D (2013) Reviewing and updating the major molecular markers for stem cells. Stem Cells Dev 22(9): 1455-1476.
29. Ramasamy S, Narayanan G, Sankaran S, Yu YH, Ahmed S (2013) Neural stem cell survival factors. Arch Biochem Biophys 534(1-2): 71-87.
30. Brescia P, Richichi C, Pelicci G (2012) Current strategies for identification of glioma stem cells: adequate or unsatisfactory? J Oncol 2012: 376894.
31. Swayne LA, Wicki-Stordeur L (2012) Ion channels in postnatal neurogenesis: potential targets for brain repair. Channels (Austin) 6(2): 69-74. Review.
32. D'Ascenzo M, Piacentini R, Casalbore P, Budoni M, Pallini R, et al. (2006) Role of L-type Ca2+ channels in neural stem/progenitor cell differentiation. Eur J Neurosci 23(4): 935-944. (Pubitemid 43344688)
33. Molenaar RJ (2011) Ion channels in glioblastoma. ISRN Neurol; 2011: 590249.
34. Zhou Z, Sun L, Wang Y, Wu Z, Geng J, et al. (2011) Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother Radiopharm 26(1): 77-83.
35. Kolenda J, Jensen SS, Aaberg-Jessen C, Christensen K, Andersen C, et al. (2011) Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol 103(1): 43-58.
36. Ledur PF, Villodre ES, Paulus R, Cruz LA, Flores DG, et al. (2012) Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells. Purinergic Signal 8(1): 39-48.
37. Xu ZY, Wang K, Li XQ, Chen S, Deng JM, et al. (2013) The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells. Ultrasonics 53(1): 232-8.
38. Gilbert CA, Ross AH (2009) Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 108(5): 1031-1038. Review.
39. Feng X, Zhou Q, Liu C, Tao ML (2012) Drug screening study using glioma stem-like cells. Mol Med Report 6(5): 1117-1120.
40. Iglesias-Rozas JR, Hopf N (2005) Histological heterogeneity of human glioblastomas investigated with an unsupervised neural network (SOM). Histol Histopathol 20(2): 351-356. (Pubitemid 40468254)
41. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114(2): 97-109. (Pubitemid 47103521)
42. Canazza A, Calatozzolo C, Fumagalli L, Bergantin A, Ghielmetti F, et al. (2011) Increased migration of a human glioma cell line after in vitro CyberKnife irradiation. Cancer Biol Ther 12(7): 629-633.
43. Zupi G, Candiloro A, Laudonio N, Carapella C, Benassi M, et al. (1988) Establishment, characterization and chemosensitivity of two human glioma derived cell lines. J Neurooncol 6(2): 169-177.
44. Savarese A, Annicchiarico-Petruzzelli M, Citro G, Zupi G, Spagnoli LG, et al. (1992) Characterisation of a human glioblastoma cell line (LI) expressing hypothalamic and pituitary hormones. Exp Brain Res 89(2): 408-414.
45. Li Z (2013) CD133: a stem cell biomarker and beyond. Exp Hematol Oncol 2(1): 17.
46. Irollo E, Pirozzi G (2013) CD133: to be or not to be, is this the real question? Am J Transl Res 5(6): 563-581. Review.
47. Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, et al. (2011) Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer 117(1): 162-174.
48. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, et al. (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14(1): 123-129. (Pubitemid 351377986)
49. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, et al. (2009) Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol 94(1): 1-19.
50. Bleau AM, Howard BM, Taylor LA, Gursel D, Greenfield JP, et al. (2008) New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg Focus 24(3-4): E28. doi:10.3171/FOC/2008/24/3-4/E27.
51. He H, Li MW, Niu CS (2012) The pathological characteristics of glioma stem cell niches. J Clin Neurosci 19(1): 121-127.
52. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, et al. (2004) SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 26(2-4): 148-165. (Pubitemid 40867972)
53. Mellodew K, Suhr R, Uwanogho DA, Reuter I, Lendahl U, et al. (2004) Nestin expression is lost in a neural stem cell line through a mechanism involving the proteasome and Notch signalling. Brain Res Dev Brain Res 151(1-2): 13-23. (Pubitemid 38887729)
54. Peng C, Li N, Ng YK, Zhang J, Meier F, et al. (2012) A unilateral negative feedback loop between miR-200 microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentiation. J Neurosci 32(38): 13292-13308.
55. MacNicol MC, Cragle CE, MacNicol AM (2011) Context-dependent regulation of Msi-mediated mRNA translation and cell cycle regulation. Cell Cycle 10(1): 39-44. Review.
56. Johannessen TC, Wang J, Skaftnesmo KO, Sakariassen PØ, Enger PØ, et al. (2009) Highly infiltrative brain tumors show reduced chemosensitivity associated with a stem cell-like phenotype. Neuropathol Appl Neurobiol 35(4): 380-393.
57. Sakakibara S, Okano H (1997) Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J Neurosci 17(21): 8300-8312. (Pubitemid 27461054)
58. Nickerson PE, Myers T, Clarke DB, Chow RL (2011) Changes in Musashi-1 subcellular localization correlate with cell cycle exit during postnatal retinal development. Exp Eye Res 92(5): 344-352.
59. Katsetos CD, Draber P, Kavallaris M (2011) Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics. Anticancer Agents Med Chem 11(8): 719-28. Review.
60. Butt AM (2011) ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. Semin Cell Dev Biol 22(2): 205-213. Review.
61. Resende RR, Majumder P, Gomes KN, Britto LR, Ulrich H (2007) P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation. Neuroscience 146(3): 1169-1181. (Pubitemid 46694133)
62. Huszthy PC, Daphu I, Niclou SP, Stieber D, Nigro JM, et al. (2012) In vivo models of primary brain tumors: pitfalls and perspectives. Neuro Oncol 14(8): 979-993.